1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with gallic acid in 14 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (gallic acid) | Trials (gallic acid) | Recent Studies (post-2010) (gallic acid) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 4,793 | 42 | 2,579 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | gallic acid (IC50) |
|---|---|---|---|
| Urokinase-type plasminogen activator | Homo sapiens (human) | 6.6 | |
| Tissue-type plasminogen activator | Homo sapiens (human) | 6.6 | |
| Plasminogen activator inhibitor 1 | Homo sapiens (human) | 6.6 | |
| Urokinase-type plasminogen activator | Mus musculus (house mouse) | 6.6 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 4.03 | |
| Matrilysin | Homo sapiens (human) | 4.03 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 4.65 | |
| Alpha-synuclein | Homo sapiens (human) | 4.43 | |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | Homo sapiens (human) | 4.03 | |
| Polypeptide N-acetylgalactosaminyltransferase 2 | Homo sapiens (human) | 1.37 | |
| Alpha-(1,3)-fucosyltransferase 7 | Homo sapiens (human) | 4.03 | |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | Homo sapiens (human) | 4.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 10 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Norman, SJ; Poyser, NL | 1 |
| Chao, W; Hanahan, DJ; Liu, H; Olson, MS | 1 |
| Bittinger, M; Dorsch, W; Kaas, A; Kreher, B; Müller, A; Wagner, H | 1 |
| Feuerstein, G; Gleason, MM; Gu, JL; Hallenbeck, J; Lysko, PG; Yue, TL | 1 |
| Buckalew, VM; Handa, RK; Strandhoy, JW | 1 |
| Feuerstein, G; Gleason, MM; Hallenbeck, J; Yue, TL | 1 |
| Srimal, RC; Srivastava, R | 1 |
| Gandhi, CR; Hanahan, DJ; Olson, MS | 1 |
| Northover, AM | 1 |
| Khan, SN; Lane, PA; Smith, AD | 1 |
| Alonso, F; Gómez-Cambronero, J; Iñarrea, P; Sánchez Crespo, M | 1 |
| Lyons, RM; Shaw, JO | 1 |
| Arriba, G; Caramelo, C; Lamas, S; López-Novoa, JM; Olivera, A; Rodriguez-Barbero, A; Rodriguez-Puyol, D; Schrier, RW | 1 |
| Löhrke, B; Neels, P; Pöhland, R; Tiemann, U; Walzel, H | 1 |
14 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and gallic acid
| Article | Year |
|---|---|
The effects of platelet-activating factor on the output of prostaglandins from the guinea-pig uterus.
Topics: Animals; Calcium; Calcium Channel Blockers; Estrus; Female; Gallic Acid; Guinea Pigs; In Vitro Techniques; Perfusion; Platelet Activating Factor; Pregnancy; Prostaglandins; Uterus | 1992 |
Platelet-activating factor-stimulated protein tyrosine phosphorylation and eicosanoid synthesis in rat Kupffer cells. Evidence for calcium-dependent and protein kinase C-dependent and -independent pathways.
Topics: Animals; Blotting, Western; Calcimycin; Calcium; Down-Regulation; Egtazic Acid; Eicosanoids; Electrophoresis, Polyacrylamide Gel; Gallic Acid; Kupffer Cells; Phosphorylation; Platelet Activating Factor; Precipitin Tests; Protein Kinase C; Radioimmunoassay; Rats; Signal Transduction; Tetradecanoylphorbol Acetate; Tyrosine | 1992 |
Antiasthmatic effects of Galphimia glauca, gallic acid, and related compounds prevent allergen- and platelet-activating factor-induced bronchial obstruction as well as bronchial hyperreactivity in guinea pigs.
Topics: Animals; Asthma; Bronchial Hyperreactivity; Bronchoconstriction; Gallic Acid; Guinea Pigs; Male; Ovalbumin; Phytotherapy; Plant Extracts; Platelet Activating Factor; Quercetin | 1992 |
Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
Topics: Animals; Azepines; Calcium; Calcium Channel Blockers; Cells, Cultured; Gallic Acid; Hybrid Cells; Phosphatidylinositols; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles | 1991 |
Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Calcium Channel Blockers; Dopamine Antagonists; Dose-Response Relationship, Drug; Furans; Gallic Acid; Haloperidol; Hematocrit; Male; Nimodipine; Platelet Activating Factor; Potassium Chloride; Rats; Rats, Inbred Strains; Renal Circulation; Vasoconstriction | 1991 |
Characterization of platelet-activating factor-induced elevation of cytosolic free-calcium level in neurohybrid NCB-20 cells.
Topics: Animals; Azepines; Calcium; Calcium Channel Blockers; Cerebral Cortex; Cricetinae; Cricetulus; Cytosol; Diterpenes; Gallic Acid; Ginkgolides; Hybrid Cells; Lactones; Mice; Neuroblastoma; Platelet Activating Factor; Quinolinium Compounds; Triazoles | 1991 |
Amplification of platelet response during acute inflammation in rats.
Topics: Acute Disease; Animals; Egtazic Acid; Gallic Acid; Heparin; Inflammation; Male; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation; Platelet Factor 4; Rats | 1990 |
Two distinct pathways of platelet-activating factor-induced hydrolysis of phosphoinositides in primary cultures of rat Kupffer cells.
Topics: Animals; Calcium; Cells, Cultured; Cholera Toxin; Chromatography, High Pressure Liquid; Egtazic Acid; Gallic Acid; In Vitro Techniques; Inositol Phosphates; Kupffer Cells; Pertussis Toxin; Phosphatidylinositols; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tetradecanoylphorbol Acetate; Time Factors; Virulence Factors, Bordetella | 1990 |
The effects of TMB-8 on the shape changes of vascular endothelial cells resulting from exposure to various inflammatory agents.
Topics: Animals; Bradykinin; Calcimycin; Calcium Channel Blockers; Dinoprostone; Endothelium, Vascular; Gallic Acid; Guinea Pigs; Histamine; In Vitro Techniques; Inflammation; Leukotrienes; Platelet Activating Factor; Vena Cava, Inferior | 1989 |
Desaggregation of PAF-acether-aggregated platelets by verapamil and TMB-8 with reversal of phosphorylation of 40K and 20K proteins.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcium Channel Blockers; Egtazic Acid; Gallic Acid; In Vitro Techniques; Lanthanum; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Proteins; Rabbits; Serotonin; Verapamil | 1985 |
The role of calcium ions in the process of acetyltransferase activation during the formation of platelet-activating factor (PAF-acether).
Topics: Acetyl-CoA C-Acetyltransferase; Acetyltransferases; Animals; Biological Transport; Calcimycin; Calcium; Enzyme Activation; Gallic Acid; In Vitro Techniques; Macrophages; Platelet Activating Factor; Rats; Rats, Inbred Strains; Zymosan | 1984 |
Requirements for different Ca2+ pools in the activation of rabbit platelets. I. release reaction and protein phosphorylation.
Topics: Animals; Blood Platelets; Blood Proteins; Calcimycin; Calcium; Gallic Acid; Lysophosphatidylcholines; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Rabbits; Serotonin; Thrombin; Time Factors | 1982 |
Effect of atrial natriuretic peptide and calcium antagonists on platelet-activating factor-induced contraction and intracellular calcium mobilization in rat mesangial cells.
Topics: Analysis of Variance; Animals; Atrial Natriuretic Factor; Calcium; Calcium Channel Blockers; Cells, Cultured; Diterpenes; Dose-Response Relationship, Drug; Fura-2; Furans; Gallic Acid; Ginkgolides; Glomerular Mesangium; Hydrogen-Ion Concentration; Lactones; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Rats; Rats, Wistar; Spectrometry, Fluorescence; Verapamil | 1994 |
Influence of inhibitors on increase in intracellular free calcium and proliferation induced by platelet-activating factor in bovine oviductal cells.
Topics: Analysis of Variance; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Cattle; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Fallopian Tubes; Female; Flufenamic Acid; Fura-2; Gallic Acid; Homeostasis; Membrane Potentials; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Platelet Activating Factor | 1999 |